Presentation is loading. Please wait.

Presentation is loading. Please wait.

C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019.

Similar presentations


Presentation on theme: "C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019."— Presentation transcript:

1 C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019

2 The Gut Microbiome & Disease Prevention
Microbiome is a collection of 39 trillion microbes in our GI tract (predominantly the colon) Healthy microbiome protects the body from disease Preclude emergence of pathogens/MDRO’s Prevent changes to the microbial metabolome Preserve healthy gut function

3 Testing Multistep testing required
One step testing-half of positives are not CDI 25% of CDI resolves on its own Do not test asymptomatic patients

4 Algorithm

5 Pediatric Testing High prevalence of asymptomatic carriage
Never routinely recommended for neonates or infants < 12 months of age with diarrhea Should not be performed in children with diarrhea 1-2 years of age unless other infectious or non-infectious causes have been excluded

6 Antibiotic Stewardship
IDSA Guidelines for decreased length of antibiotic therapies UK eliminated the most toxic subtype of C. difficile with stewardship (Fluorquinolones and Cephalosporin's) 41% increase in abx prescriptions in the outpatient setting by NP’s/PA’s. 15% decrease ordering by physicians

7 Community Acquired On the increase Usually less severe infection
How is it spread in those patients without healthcare contact? 82% with outpatient exposure It's on surfaces 39.7% on shoe bottoms in one community study

8 Fecal Transplants Can prevent reoccurrence
Many failures related to incorrect initial testing Trials in process to use for initial acute phase diagnosis In the near future-capsules

9 The Future is Close Vaccines in clinical trials
New antibiotics with narrow spectrum focus 40 new antibiotics in development-only 1 in phase three trial stage Other compounds to maintain microbiome Extended tapers of Vancomycin-QOD FMT as primary treatment for CDI

10 SARMC Criteria for Testing
Patient must have: ≥3 watery stools in the past 24 hrs (sample conforms to specimen container) Formed stool samples will be rejected. In rare suspicion of ileus/toxic megacolon 2ndary to C diff, consider rectal swab. AND At least 1 of the following: o Abdominal pain/discomfort (cramping, bloating) o Antibiotic therapy within last 3 months o Gastric acid suppression (proton pump inhibitor or H2 blocker) o GI surgery within last month o Resident of SNF, age >65 o Chemotherapy within last month o Hospitalization within last 2 months o C diff infection within last 90 days (unless tested within last 7 days or tested positive within last 30 days)

11 Criteria None of the following are applicable:
Laxatives, Bowel prep or other current medications that are known to cause diarrhea within last 3 days TPN infusion Tube feedings Other infectious or parasitic sources of diarrhea are unlikely Acute resolution of bowel obstruction Expected post-operative diarrhea (post-operative day 0-2)--if unsure, clarify with provider Ileostomy or short bowel syndrome

12 Testing Algorithm Antigen/toxin testing first PCR if indicated
Remember never order for test of cure

13 Removal for Isolation Has completed at least seven days of therapy
Has formed stool Is capable of performing personal and hand hygiene with soap and water.

14 Questions?


Download ppt "C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019."

Similar presentations


Ads by Google